We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAP icon
776
SAP
SAP
$219B
-24,597
Closed -$3.32M
SES icon
777
SES AI
SES
$218M
-32,770
Closed -$324K
SKYT icon
778
SkyWater Technology
SKYT
$1.6B
-82,259
Closed -$2.24M
SMWB icon
779
Similarweb
SMWB
$638M
-103,380
Closed -$2.16M
SRRK icon
780
Scholar Rock
SRRK
$5.49B
-136,359
Closed -$4.5M
STRO icon
781
Sutro Biopharma
STRO
$416M
-21,951
Closed -$4.15M
STZ icon
782
Constellation Brands
STZ
$22.4B
-57,369
Closed -$12.1M
SUPN icon
783
Supernus Pharmaceuticals
SUPN
$2.67B
-53,915
Closed -$1.44M
SWIM icon
784
Latham Group
SWIM
$662M
-87,955
Closed -$1.44M
TASK icon
785
TaskUs
TASK
$582M
-17,500
Closed -$1.16M
TER icon
786
Teradyne
TER
$57.2B
-1,206,563
Closed -$132M
TGTX icon
787
TG Therapeutics
TGTX
$7.07B
-106,932
Closed -$3.56M
TNYA icon
788
Tenaya Therapeutics
TNYA
$158M
-150,080
Closed -$3.1M
TRI icon
789
Thomson Reuters
TRI
$44.4B
-461,178
Closed -$53.7M
TTWO icon
790
Take-Two Interactive
TTWO
$45.8B
-127,634
Closed -$19.7M
TVTX icon
791
Travere Therapeutics
TVTX
$5.11B
-145,918
Closed -$3.54M
TWLO icon
792
Twilio
TWLO
$29.8B
-33,857
Closed -$10.8M
TXN icon
793
Texas Instruments
TXN
$246B
-112,094
Closed -$21.5M
UHS icon
794
Universal Health Services
UHS
$10.2B
-54,496
Closed -$7.54M
ULCC icon
795
Frontier Group Holdings
ULCC
$1.77B
-291,970
Closed -$4.61M
VRSN icon
796
VeriSign
VRSN
$27B
-64,748
Closed -$13.3M
XENE icon
797
Xenon Pharmaceuticals
XENE
$6.02B
-199,984
Closed -$3.06M
XMTR icon
798
Xometry
XMTR
$4.81B
-5,765
Closed -$332K
XRX icon
799
Xerox
XRX
$411M
-428,840
Closed -$8.65M
ZETA icon
800
Zeta Global
ZETA
$5.62B
-467,067
Closed -$2.74M

Similar funds

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.